Boston Partners - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boston Partners ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$6,344,000
+42.0%
182,3010.0%0.01%
+33.3%
Q3 2016$4,468,000
+2.5%
182,3010.0%0.01%0.0%
Q2 2016$4,361,000
+2.2%
182,3010.0%0.01%0.0%
Q1 2016$4,266,000
+151.1%
182,301
+223.9%
0.01%
+200.0%
Q4 2015$1,699,00056,2810.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,344,620$116,393,0006.64%
Consonance Capital Management LP 1,026,902$35,736,0003.92%
FALCON POINT CAPITAL, LLC 801,944$27,908,0003.74%
Credit Capital Investments LLC 72,813$2,534,0003.24%
Crosspoint Capital Strategies, LLC 99,274$3,455,0003.07%
Camber Capital Management LP 611,390$21,276,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 40,901$1,423,0001.04%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 344,103$11,974,0000.83%
STELLIAM INVESTMENT MANAGEMENT, LP 572,500$19,923,0000.66%
AlphaOne Investment Services, LLC 66,105$2,301,0000.64%
View complete list of AMAG PHARMACEUTICALS INC shareholders